Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Lipids and Cardiovascular Risk After Switching HIV-1 Patients on Nevirapine and Emtricitabine/Tenofovir-DF to Rilpivirine/Emtricitabine/Tenofovir-DF.

Rokx C, Verbon A, Rijnders BJ.

AIDS Res Hum Retroviruses. 2015 Jan 27. [Epub ahead of print]

PMID:
25625211
[PubMed - as supplied by publisher]
2.

Direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. Validation of a new Aspergillus real-time PCR.

Chong GM, van de Sande WW, Dingemans GJ, Gaajetaan GR, Vonk AG, Hayette MP, van Tegelen DW, Simons GF, Rijnders BJ.

J Clin Microbiol. 2015 Jan 7. pii: JCM.03216-14. [Epub ahead of print]

PMID:
25568431
[PubMed - as supplied by publisher]
3.

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study.

Rokx C, Blonk M, Verbon A, Burger D, Rijnders BJ.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19789. doi: 10.7448/IAS.17.4.19789. eCollection 2014.

PMID:
25397533
[PubMed - in process]
Free PMC Article
4.

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort.

Rokx C, Fibriani A, van de Vijver D, Verbon A, Schutten M, Gras L, Rijnders BJ.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19491. doi: 10.7448/IAS.17.4.19491. eCollection 2014.

PMID:
25394000
[PubMed - in process]
Free PMC Article
5.

The new hepatitis C era: the guidelines are now available, reimbursement not yet...

Hullegie SJ, Rijnders BJ.

Neth J Med. 2014 Oct;72(8):386-7. No abstract available.

PMID:
25387550
[PubMed - in process]
Free Article
6.

Safety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis.

van der Geest PJ, Dieters EI, Rijnders B, Groeneveld J.

BMC Infect Dis. 2014 Oct 28;14(1):575. [Epub ahead of print]

PMID:
25348856
[PubMed - as supplied by publisher]
Free PMC Article
7.

Increased Virological Failure in Naive HIV-1-Infected Patients Taking Lamivudine Compared With Emtricitabine in Combination With Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort.

Rokx C, Fibriani A, van de Vijver DA, Verbon A, Schutten M, Gras L, Rijnders BJ; AIDS Therapy Evaluation in the Netherlands (ATHENA) National Observational Cohort.

Clin Infect Dis. 2015 Jan 1;60(1):143-53. doi: 10.1093/cid/ciu763. Epub 2014 Oct 1.

PMID:
25273080
[PubMed - in process]
8.

The Efficacy, Pharmacokinetics, and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1-Infected Patients.

Rokx C, Blonk M, Verbon A, Burger D, Rijnders BJ.

J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):36-39.

PMID:
25247434
[PubMed - as supplied by publisher]
9.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group.

Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.

PMID:
25042234
[PubMed - indexed for MEDLINE]
10.

Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations.

Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin CA, El-Sadr W, d'Arminio Monforte A, Phillips AN, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren JD, Law MG; D:A:D study group.

HIV Med. 2014 Nov;15(10):595-603. doi: 10.1111/hiv.12162. Epub 2014 May 19.

PMID:
24840675
[PubMed - in process]
11.

Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy.

Rokx C, Verbon A, Rijnders BJ.

HIV Med. 2014 Nov;15(10):611-4. doi: 10.1111/hiv.12157. Epub 2014 Apr 16.

PMID:
24738660
[PubMed - in process]
12.

Temporary treatment during primary HIV infection does not affect virologic response to subsequent long-term treatment.

Grijsen ML, Wit FW, Jurriaans S, Kroon FP, Schippers EF, Koopmans P, Gras L, Lange JM, Prins JM; Primo-SHM Study Group.

PLoS One. 2014 Apr 3;9(4):e89639. doi: 10.1371/journal.pone.0089639. eCollection 2014.

PMID:
24699072
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.

Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group.

BMC Nephrol. 2014 Mar 25;15:51. doi: 10.1186/1471-2369-15-51.

PMID:
24666792
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis.

Behrens G, Rijnders B, Nelson M, Orkin C, Cohen C, Mills A, Elion RA, Vanveggel S, Stevens M, Rimsky L, Thorpe D, Bosse M, White K, Zhong L, DeMorin J, Chuck SK.

AIDS Patient Care STDS. 2014 Apr;28(4):168-75. doi: 10.1089/apc.2013.0310. Epub 2014 Mar 24.

PMID:
24660840
[PubMed - indexed for MEDLINE]
15.

Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient.

Hassing RJ, Melles DC, Goessens WH, Rijnders BJ.

Infection. 2014 Aug;42(4):789-90. doi: 10.1007/s15010-014-0594-4. Epub 2014 Feb 2. No abstract available.

PMID:
24488332
[PubMed - in process]
16.

Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases.

Colbers A, Gingelmaier A, van der Ende M, Rijnders B, Burger D.

AIDS. 2014 Jan 14;28(2):288-90. doi: 10.1097/QAD.0000000000000100. No abstract available.

PMID:
24413315
[PubMed - indexed for MEDLINE]
17.

Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.

Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA; D:A:D Study Group.

BMC Infect Dis. 2013 Oct 9;13:471. doi: 10.1186/1471-2334-13-471.

PMID:
24106926
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands.

Smit M, Smit C, Geerlings S, Gras L, Brinkman K, Hallett TB, de Wolf F; Athena Observational Cohort.

PLoS One. 2013 Sep 30;8(9):e76071. doi: 10.1371/journal.pone.0076071. eCollection 2013.

PMID:
24098764
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective.

Vriend HJ, Lugnér AK, Xiridou M, Schim van der Loeff MF, Prins M, de Vries HJ, Geerlings SE, Prins JM, Rijnders BJ, van Veen MG, Fennema JS, Postma MJ, van der Sande MA.

AIDS. 2013 Sep 10;27(14):2281-90. doi: 10.1097/QAD.0b013e32836281ee.

PMID:
24067620
[PubMed - indexed for MEDLINE]
20.

Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men.

Xiridou M, Vriend HJ, Lugner AK, Wallinga J, Fennema JS, Prins JM, Geerlings SE, Rijnders BJ, Prins M, de Vries HJ, Postma MJ, van Veen MG, Schim van der Loeff MF, van der Sande MA.

BMC Infect Dis. 2013 Sep 18;13:436. doi: 10.1186/1471-2334-13-436.

PMID:
24047261
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk